Skip to main content

Advertisement

SpringerLink
Log in

Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

CYP2W1 overexpression has been reported in a variety of human cancers. However, the role of CYP2W1 in hepatocellular carcinoma (HCC) remains unclear. This study was designed to evaluate the expression and prognostic significance of CYP2W1 in human HCC. Real-time quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was conducted to detect CYP2W1 messenger RNA (mRNA) expression in 41 pairs of fresh-frozen HCC tissues and adjacent noncancerous tissues. In addition, CYP2W1 expression was analyzed by immunohistochemistry in 133 clinicopathologically characterized HCC cases. The relationship between CYP2W1 expression and clinicopathological features was analyzed by appropriate statistics. Kaplan-Meier analysis and Cox proportional hazards regression models were used to investigate the correlation between CYP2W1 expression and prognosis of HCC patients. The relative mRNA expression of CYP2W1 was significantly higher in HCC tissues than in adjacent noncancerous tissues (P < 0.001). In addition, CYP2W1 expression was significantly correlated with tumor size (P = 0.023), histological differentiation (P = 0.04), and tumor stage (P = 0.014). The Kaplan-Meier survival curves indicated that patients with high expression of CYP2W1 had shorter overall survival than those with low expression (P < 0.001). Furthermore, Cox regression analyses showed that CYP2W1 expression was an independent predictor of overall survival. Our data suggest that CYP2W1 could play an important role in HCC and might serve as a valuable prognostic marker and potential target for gene therapy in the treatment of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107.

    Article  PubMed  Google Scholar 

  2. Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012;62:394–9. doi:10.3322/caac.21161.

    Article  PubMed  Google Scholar 

  3. Karlgren M, Gomez A, Stark K, Svärd J, Rodriguez-Antona C, Oliw E, et al. Ramón y Cajal S, Johansson I, Ingelman-Sundberg M. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1. Biochem Biophys Res Commun. 2006;341:451–8.

    Article  CAS  PubMed  Google Scholar 

  4. Edler D, Stenstedt K, Ohrling K, Hallström M, Karlgren M, Ingelman-Sundberg M, et al. The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer—a pilot study. Eur J Cancer. 2009;45:705–12. doi:10.1016/j.ejca.2008.11.031.

    Article  CAS  PubMed  Google Scholar 

  5. Stenstedt K, Hallstrom M, Johansson I, Ingelman-Sundberg M, Ragnhammar P, Edler D. The expression of CYP2W1: a prognostic marker in colon cancer. Anticancer Res. 2012;32:3869–74.

    PubMed  Google Scholar 

  6. Gomez A, Karlgren M, Edler D, Bernal ML, Mkrtchian S, Ingelman-Sundberg M. Expression of CYP2W1 in colon tumors: regulation by gene methylation. Pharmacogenomics. 2007;8:1315–25. doi:10.2217/14622416.8.10.1315.

    Article  CAS  PubMed  Google Scholar 

  7. Du L, Hoffman SM, Keeney DS. Epidermal CYP2 family cytochromes P450. Toxicol Appl Pharmacol. 2004;195:278–87.

    Article  CAS  PubMed  Google Scholar 

  8. Du L, Neis MM, Ladd PA, Lanza DL, Yost GS, Keeney DS. Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells. Toxicol Appl Pharmacol. 2006;213:135–44.

    Article  CAS  PubMed  Google Scholar 

  9. Du L, Neis MM, Ladd PA, Keeney DS. Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J Pharmacol Exp Ther. 2006;319:1162–71. doi:10.1124/jpet.106.111724.

    Article  CAS  PubMed  Google Scholar 

  10. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003;22:5093–107. doi:10.1038/sj.onc.1206557.

    Article  CAS  PubMed  Google Scholar 

  11. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16. doi:10.1053/j.gastro.2004.09.011.

    Article  PubMed  Google Scholar 

  12. Tang ZY, Ye SL, Liu YK, Qin LX, Sun HC, Ye QH, et al. A decade’s studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:187–96.

    Article  PubMed  Google Scholar 

  13. Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery. 2007;141:196–202. doi:10.1016/j.surg.2006.06.033.

    Article  PubMed  Google Scholar 

  14. Zhou J, Tang ZY, Wu ZQ, Zhou XD, Ma ZC, Tan CJ, et al. Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterol. 2006;53:275–80.

    Google Scholar 

Download references

Conflict of interest

None

Author information

Authors and Affiliations

  1. Department of Hepatobiliary Surgery, Beijing Ditan Hospital, Capital Medical University, No. 8 Jingshun East Street, Beijing, 100015, China

    Ke Zhang, Li Jiang, Rong He, Bao-Liang Li, Zhe Jia, Rong-Hai Huang & Yi Mu

Authors
  1. Ke Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rong He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bao-Liang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhe Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rong-Hai Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yi Mu.

Additional information

Ke Zhang and Li Jiang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, K., Jiang, L., He, R. et al. Prognostic value of CYP2W1 expression in patients with human hepatocellular carcinoma. Tumor Biol. 35, 7669–7673 (2014). https://doi.org/10.1007/s13277-014-2023-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2023-9

Keywords

Search

Navigation